Nexalin Tech
NXL0.44208.15% ( -0.0392 )
Nexalin Tech (NXL)
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United Sta...
- Open
- 0.4954
- High
- 0.4954
- Low
- 0.4390
- Prev. Close
- 0.4812
- Volume
- 225.73K
- Turnover
- 98.22K
- Avg Price
- 0.4351
- Bid/Ask Ratio
- --
- Amplitude
- 11.72%
- 52wk High
- 2.0000
- Volume Ratio
- 1.08
- Turnover Ratio
- 1.20%
Nexalin Tech Analyst Rating
View MoreForecast & Rating
May 20, 2026Price forecast
$2.00352.49%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks · 10 hours ago
Nexalin Appeals Nasdaq Delisting Following Compliance Shortfalls
- PUBT · 11 hours ago
Nexalin appeals Nasdaq delisting notice after failing $1 minimum bid requirement
- PUBT · Jun 29 at 04:31 PM
Nexalin Technology announces annual shareholder meeting
- Unusual Whales · Jun 16 at 08:17 AM
Nexalin Technology Announces Two Clinical Abstracts Accepted for Presentation at the 2026 NYC Neuromodulation Conference Highlighting Preliminary Clinical Results Across Anxiety, Depression, Insomnia and Quality of Life
- Unusual Whales · Jun 10 at 08:17 AM
Nexalin Technology Reports Compelling Clinical Trial Results in Brazil to Support Product Launch. Trial Demonstrates 77.8% Anxiety Response Rate and Durable Benefits Across Depression, Insomnia and Quality of Life as Company Advances Brazilian Sales Plan.
- benzinga_article · Jun 10 at 08:01 AM
EXCLUSIVE: Nexalin Brazil Trial Shows Benefits Across Anxiety, Sleep And Quality Of Life
